DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Kidney Disease Research 52

Journal of the American Heart Association

MARCH 13, 2025

We aimed to evaluate whether proteinuria in young people is associated with an increased risk of SCA.Methods and ResultsIndividuals aged between 20 and 39 years who underwent health screening between 2009 and 2012 in South Korea were included (n=6 891 400). Urine protein was measured using the spot urine dipstick method.

Cardiac Arrest 73

Cardiac Arrest Kidney Disease Risk Factors Outcomes 73

HCPLive

MARCH 13, 2024

The KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease is an update to the KDIGO 2012 CKD Guideline.

Kidney Disease 52

Kidney Disease 52

Open Heart

APRIL 24, 2024

Results Data were collected in April 2012 to January 2014 and in June 2021 to December 2022. Frailty, chronic kidney disease and ischaemic heart disease increased significantly versus the first period (p<0.001). Statistical significance is determined at p<0.05. and 29.2%, p<0.001).

Heart Failure 52

Heart Failure Preserved Ejection Fraction ACE Inhibitor Pharmacology 52

Open Heart

JUNE 1, 2022

Methods Data were collected prospectively into the Sheffield HEArt Failure (SHEAF) registry between April 2012 and January 2020. Mortality was increased with male gender, valvular heart disease and chronic kidney disease. to 0.97; p=0.02).

Heart Failure 52

Heart Failure Kidney Disease Atrial Fibrillation Hypertension 52

DAIC

MARCH 25, 2025

25 include Efficacy and safety of finerenone across the spectrum of kidney risk in heart failure with mildly reduced or preserved ejection fraction during the session;"Innovations and Insights in Heart Failure With Preserved Ejection Fraction: Emerging Therapies, Biomarkers and Mechanistic Studies." Additional ACC.25

Preserved Ejection Fraction 52

Preserved Ejection Fraction Heart Failure Research Academic 52

Cardiometabolic Health Congress

JULY 10, 2024

Bakris’s distinguished career in medicine spanned over four decades, marked by significant contributions to the fields of diabetic kidney disease, hypertension, and nephropathy progression. His work was particularly influential in understanding racial disparities in disease progression and developing targeted interventions.

Hypertension 52

Hypertension Education Blood Pressure Kidney Disease 52